Office of the Director, National Institutes of Health; Notice of Meeting, 9243 [2014-03395]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 32 / Tuesday, February 18, 2014 / Notices
reduce the risk of extension ladder
slipping and tipping and, ultimately,
will reduce the number of fall incidents
and injuries—benefitting construction
workers, employers, contractors and
workplace insurers.
Potential Commercial Applications:
• Retrofitting existing ladders to
provide automated, multisensory
feedback for improved compliance
with OSHA and ANSI ladder-angle
safety guidelines
• Ladder manufacturing companies
• Construction contractors, retailers and
insurers
• Training tool to aid worker safety
education and adherence
Competitive Advantages:
• Direct, multimodal user feedback
reduces the time for accurate, safe
ladder positioning compared to
bubble-level indicator,
anthropometric and sight- based
ladder-positioning methods
• Visual, auditory and tactile feedback
provide increased efficient-setup and
safety
• Technology can be incorporated as an
attachable, device which may be
affixed to a ladder or integrated as an
app for a mobile/tablet device
• Automated feedback ensures ladders
are angled to OSHA and ANSI safety
specifications
Development Stage:
• In situ data available (on-site)
• Prototype
Inventors: Peter Simeonov, Hongwei
Hsiao, John Powers (all of CDC)
Publication: Simeonov P, et al.
Research to improve extension ladder
angular positioning. Appl Ergon. 2013
May;44(3):496–502. [PMID 23177178]
Intellectual Property: HHS Reference
No. E–141–2013/0—U.S. Patent No
8,167,087 issued 01 May 2012
Licensing Contact: Whitney Blair, J.D.,
M.P.H.; 301–435–4937; whitney.blair@
nih.gov.
Dates: February 13, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–03411 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
tkelley on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
VerDate Mar<15>2010
20:58 Feb 14, 2014
Jkt 232001
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: March 12, 2014.
Time: 9:30 a.m. to 3:30 p.m.Agenda: The
NIH Recombinant DNA Advisory Committee
(RAC) will review and discuss selected
human gene transfer protocols and related
data management activities. Please check the
meeting agenda at OBA Meetings Page
(available at the following URL: https://
oba.od.nih.gov/rdna_rac/rac_meetings.html)
for more information.
Place: National Institutes of Health,
Rockledge II, Conference Room 9100, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Chris Nice, Program
Assistant, Office of Biotechnology Activities,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892, 301–
496–9838, nicelc@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
oba.od.nih.gov/rdna/rdna.html, where an
agenda and any additional information for
the meeting will be posted when available.
OMB’s ‘‘Mandatory Information
Requirements for Federal Assistance Program
Announcements’’ (45 FR 39592, June 11,
1980) requires a statement concerning the
official government programs contained in
the Catalog of Federal Domestic Assistance.
Normally NIH lists in its announcements the
number and title of affected individual
programs for the guidance of the public.
Because the guidance in this notice covers
virtually every NIH and Federal research
program in which DNA recombinant
molecule techniques could be used, it has
been determined not to be cost effective or
in the public interest to attempt to list these
programs. Such a list would likely require
several additional pages. In addition, NIH
could not be certain that every Federal
program would be included as many Federal
agencies, as well as private organizations,
both national and international, have elected
to follow the NIH Guidelines. In lieu of the
individual program listing, NIH invites
readers to direct questions to the information
address above about whether individual
programs listed in the Catalog of Federal
Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
9243
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 12, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03395 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social Sciences and Population Studies B
Study Section.
Date: February 28, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Blvd., Long Beach, CA 90802.
Contact Person: Valerie Durrant, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 827–
6390, durrantv@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: AIDS and Related
Research Integrated Review Group; HIV/
AIDS Vaccines Study Section.
Date: March 7, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue NW., Washington, DC
20036.
Contact Person: Mary Clare Walker, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5208,
MSC 7852, Bethesda, MD 20892, (301) 435–
1165, walkermc@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDS
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 79, Number 32 (Tuesday, February 18, 2014)]
[Notices]
[Page 9243]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03395]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: March 12, 2014.
Time: 9:30 a.m. to 3:30 p.m.Agenda: The NIH Recombinant DNA
Advisory Committee (RAC) will review and discuss selected human gene
transfer protocols and related data management activities. Please
check the meeting agenda at OBA Meetings Page (available at the
following URL: https://oba.od.nih.gov/rdna_rac/rac_meetings.html)
for more information.
Place: National Institutes of Health, Rockledge II, Conference
Room 9100, 6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Chris Nice, Program Assistant, Office of
Biotechnology Activities, National Institutes of Health, 6705
Rockledge Drive, Suite 750, Bethesda, MD 20892, 301-496-9838,
nicelc@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://oba.od.nih.gov/rdna/rdna.html, where an agenda and any
additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 12, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03395 Filed 2-14-14; 8:45 am]
BILLING CODE 4140-01-P
